C4 Therapeutics, Inc. (CCCC) — SC 13G/A Filings
All SC 13G/A filings from C4 Therapeutics, Inc.. Browse 10 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (10)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Jul 10, 2024
- SC 13G/A Filing — Mar 8, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
Wasatch Advisors Holds 14.5% Stake in C4 Therapeutics
— Feb 9, 2024 Risk: low
Wasatch Advisors LP, an investment adviser, filed an amended SC 13G/A on February 9, 2024, disclosing an ownership of 7,138,949 shares of C4 Therapeutics, Inc. -
Soleus Capital Amends C4 Therapeutics Stake as of Dec 31, 2023
— Feb 2, 2024
Soleus Capital Master Fund, L.P. filed an amended SC 13G/A on February 2, 2024, indicating a change in their beneficial ownership of C4 Therapeutics, Inc. commo
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX